Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Chlorhexidine Acetate 0.05% |
| Active Ingredient: | Chlorhexidine acetate 0.05%w/v |
| Dosage Form: | Antiseptic solution |
| New Zealand Sponsor: | Baxter Healthcare Limited |
| Manufacturer: | Baxter Healthcare Pty Limited, Sydney, Australia |
| Product: | Chlorhexidine Acetate 0.1% |
| Active Ingredient: | Chlorhexidine acetate 0.1%w/v |
| Dosage Form: | Antiseptic solution |
| New Zealand Sponsor: | Baxter Healthcare Limited |
| Manufacturer: | Baxter Healthcare Pty Limited, Sydney, Australia |
Dated this 10th day of February 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).